# LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE
> **NDA205355** · New Drug Application · Sponsor: HETERO LABS LTD III · Approved 2014-03-14
## Drug
- **FDA Application Number:** NDA205355
- **Application type:** New Drug Application
- **Brand name:** LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE
- **Generic name:** Lamivudine
- **Active ingredients:** LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** HETERO LABS LTD III
- **First approval:** 2014-03-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205355)
---
*MORVS · CC0 1.0*